BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15557427)

  • 21. The study of c-Src kinase and pStat3 protein expression in retinoblastoma.
    Mohan A; Mallikarjuna K; Venkatesan N; Abhyankar D; Parikh PM; Krishnakumar S
    Exp Eye Res; 2006 Oct; 83(4):736-40. PubMed ID: 16716300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
    Souza Filho JP; Martins MC; Caissie AL; Torres VL; Fernandes LH; Erwenne CM; Burnier MN
    Clin Exp Ophthalmol; 2005 Jun; 33(3):279-84. PubMed ID: 15932532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
    Youssef NS; Said AM
    Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p63 and p73 in retinoblastoma: a clinicopathological correlation study.
    Adithi M; Nalini V; Kandalam M; Krishnakumar S
    Exp Eye Res; 2008 Oct; 87(4):312-8. PubMed ID: 18619959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
    Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
    Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
    Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracranial malignancy in patients with bilateral retinoblastoma.
    Donoso LA; Shields JA; Felberg NT; Martyn LJ; Truex RC; D'Cruz CA
    Retina; 1981; 1(1):67-74. PubMed ID: 15633409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
    Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
    Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
    Schwimer CJ; Prayson RA
    Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of B7H3 expression in retinoblastoma.
    Ganesan B; Parameswaran S; Sharma A; Krishnakumar S
    Sci Rep; 2020 Jun; 10(1):10185. PubMed ID: 32576886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
    Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
    Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological parameters and expression of P-glycoprotein and MRP-1 in retinoblastoma.
    Kamburoğlu G; Kiratli H; Söylemezoğlu F; Bilgiç S
    Ophthalmic Res; 2007; 39(4):191-7. PubMed ID: 17596751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of TAZ indicates a poor prognosis in retinoblastoma.
    Zhang Y; Xue C; Cui H; Huang Z
    Diagn Pathol; 2015 Oct; 10():187. PubMed ID: 26464030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histopathologic findings in retinoblastoma].
    de Souza Filho JP; Martins MC; Torres VL; Dias AB; Lowen MS; Pires LA; Erwenne CM
    Arq Bras Oftalmol; 2005; 68(3):327-31. PubMed ID: 16059563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The extension of retinoblastoma into neighboring structures].
    Bosun I; Simionescu C
    Oftalmologia; 1998; 44(3):47-52. PubMed ID: 10418613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma.
    Singh L; Pushker N; Saini N; Sen S; Sharma A; Bakhshi S; Chawla B; Kashyap S
    Clin Exp Ophthalmol; 2015 Apr; 43(3):259-67. PubMed ID: 25132102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Follow-up of retinoblastoma during homeopathic therapy].
    Käsmann-Kellner B; Graf N; Elflein E; Ruprecht KW; Sitzmann CF
    Klin Monbl Augenheilkd; 1999 Apr; 214(4):aA12-6. PubMed ID: 10407798
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country.
    Orellana ME; Fernandes BF; Arean C; Pifano I; Al-Kandari A; Burnier MN
    J Pediatr Ophthalmol Strabismus; 2009; 46(5):294-9. PubMed ID: 19791727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
    Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
    Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.